Evidence map›Paper›PMID 39505846›Full record

ArticleNature communications2024

Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade.

Mayra Cruz Tleugabulova, Sandra P Melo, Aaron Wong, Alexander Arlantico, Meizi Liu, Joshua D Webster, Julia Lau, Antonie Lechner, Basak Corak, Jonathan J Hodgins and 17 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The role of myeloid immune cells in lung epithelial repair.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  3. Article
  4. Review
  5. The impact of hypoxia and glycolysis on liver fibrosis.Journal of translational medicine · 2026
    Article
  6. Article
  7. A population-scale atlas of blood and tissue in lupus nephritis.bioRxiv : the preprint server for biology · 2026
    Article
  8. RIPK3 Orchestrates Scar-Associated Macrophage Dysfunction to Drive Pulmonary Fibrosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Single-Cell Insights Into Macrophage Subtypes in Pulmonary Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  16. Monocyte-Derived LGMNResearch (Washington, D.C.) · 2026
    Article
  17. Article
  18. Scar wars: the viral menace.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  19. The Landscape of SPP1Immunology · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Mayra Cruz Tleugabulova *Department of Cancer Immunology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.ORCID 0000-0001-8105-856X
Sandra P Melo *Department of Bioinformatics, Genentech Research and Early Development, South San Francisco, CA, 94080, USA. melocars@gene.com.ORCID 0009-0000-8143-5417
Aaron WongDepartment of Translational Immunology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Alexander ArlanticoDepartment of Translational Immunology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Meizi LiuDepartment of Medicine, Washington University School of Medicine, St Louis, MO, 63110, USA.ORCID 0000-0002-7633-3384
Joshua D WebsterDepartment of Research Pathology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Julia LauDepartment of Proteomic and Genomic Technologies, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Antonie LechnerDepartment of Physiology, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-1636-3354
Basak CorakDepartment of Physiology, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-8255-9793
Jonathan J HodginsDepartment of Research Biology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.ORCID 0000-0002-0390-5599
Venkata S GarlapatiDepartment of Research Biology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Marco De SimoneDepartment of Proteomic and Genomic Technologies, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Ben KorinDepartment of Research Biology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.ORCID 0000-0001-8867-7902
Shimrit AvrahamDepartment of Research Biology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.ORCID 0000-0001-6331-8401
Jessica LundDepartment of Proteomic and Genomic Technologies, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Surinder JeetDepartment of Translational Immunology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Alexander ReissDepartment of Translational Immunology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Hannah BenderDepartment of Research Pathology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Cary D AustinDepartment of Research Pathology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Spyros DarmanisDepartment of Proteomic and Genomic Technologies, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Zora ModrusanDepartment of Proteomic and Genomic Technologies, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Hans BrightbillDepartment of Translational Immunology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Steffen DurinckDepartment of Bioinformatics, Genentech Research and Early Development, South San Francisco, CA, 94080, USA.
Michael S DiamondDepartment of Medicine, Washington University School of Medicine, St Louis, MO, 63110, USA.ORCID 0000-0002-8791-3165
Christoph SchneiderDepartment of Physiology, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-0452-2960
Andrey S ShawDepartment of Research Biology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA. shawa6@gene.com.ORCID 0000-0001-5685-0272
Maximilian NitschkéDepartment of Research Biology, Genentech Research and Early Development, South San Francisco, CA, 94080, USA. nitschkm@gene.com.ORCID 0009-0006-7812-3977

Funding

Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2R01AI157155 · NIAID · WASHINGTON UNIVERSITY · PI BARIC, RALPH S, CROWE, JAMES E · 2020 to 2024
$6.0M
NIAID NIH HHS R01 AI157155
6 · The paper itself

Abstract

Macrophages are pleiotropic and diverse cells that populate all tissues of the body. Besides tissue-specific resident macrophages such as alveolar macrophages, Kupffer cells, and microglia, multiple organs harbor at least two subtypes of other resident macrophages at steady state. During certain circumstances, like tissue insult, additional subtypes of macrophages are recruited to the tissue from the monocyte pool. Previously, a recruited macrophage population marked by expression of Spp1, Cd9, Gpnmb, Fabp5, and Trem2, has been described in several models of organ injury and cancer, and has been linked to fibrosis in mice and humans. Here, we show that Notch2 blockade, given systemically or locally, leads to an increase in this putative pro-fibrotic macrophage in the lung and that this macrophage state can only be adopted by monocytically derived cells and not resident alveolar macrophages. Using a bleomycin and COVID-19 model of lung injury and fibrosis, we find that the expansion of these macrophages before lung injury does not promote fibrosis but rather appears to ameliorate it. This suggests that these damage-associated macrophages are not, by themselves, drivers of fibrosis in the lung.

Indexed as

BleomycinLung InjuryMacrophagesMacrophages, AlveolarPulmonary FibrosisReceptor, Notch2AnimalsCOVID-19Disease Models, AnimalFemaleHumansLungMaleMiceMice, Inbred C57BLMonocytesBleomycinNotch2 protein, mouseReceptor, Notch2

Identifiers

PMID39505846
PMCPMC11541919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.